{
  "docId": "019de516-a80e-7369-bef2-cb942c391804",
  "docSlug": "7dbeec795af717930d34b2c0014ea723",
  "documentTitle": "Oculis | Results Presentation Deck | 33 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 24,
  "pageCount": 33,
  "prevPage": 23,
  "nextPage": 25,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de516-a80e-7369-bef2-cb942c391804/24",
  "deckHref": "/decks/019de516-a80e-7369-bef2-cb942c391804",
  "deckJsonHref": "/decks/019de516-a80e-7369-bef2-cb942c391804.json",
  "deckAnchorHref": "/decks/019de516-a80e-7369-bef2-cb942c391804#slide-24",
  "components": [
    {
      "bbox": {
        "h": 0.091,
        "w": 0.359,
        "x": 0.609,
        "y": 0.363
      },
      "kind": "list",
      "text": "Pain: Improve absence of ocular pain (Primary Endpoint)\n75.5% with OCS-01 vs 52.0% with vehicle (p < 0.0001)",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0280f4ef-71d6-4b96-9dd5-d3dc5cc33197",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.091,
        "w": 0.399,
        "x": 0.099,
        "y": 0.363
      },
      "kind": "list",
      "text": "Inflammation: Improve absence of anterior chamber cells (Primary Endpoint)\n57.2% with OCS-01 vs 24.0% with vehicle (p < 0.0001)",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c8e1a5a2-555b-4057-bf14-b2885c287239",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.899,
        "x": 0.033,
        "y": 0.77
      },
      "kind": "list",
      "text": "Next Step\nCommence a second Phase 3 trial to support NDA submission of OCS-01 for the Treatment of Inflammation and Pain Following Ocular Surgery",
      "attrs": {},
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1cbd3a4b-cc16-42a0-a22f-c31fce83f91e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.324,
        "x": 0.029,
        "y": 0.617
      },
      "kind": "paragraph",
      "text": "No unexpected safety findings observed",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9640ac45-b218-4597-8269-4c00bb8492e7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.048,
        "w": 0.701,
        "x": 0.029,
        "y": 0.216
      },
      "kind": "paragraph",
      "text": "OCS-01 has met the primary endpoints in OPTIMIZE Phase 3 trial, showing superiority over vehicle for treatment of inflammation and pain following cataract surgery",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b11c5a74-f3d5-4122-9915-1b2506d43d59",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.012,
        "w": 0.47,
        "x": 0.026,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Data, analysis, and conclusions are preliminary, and subject to change as full analysis is ongoing.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9089dd7c-630e-472e-a423-8b004263463d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.029,
        "w": 0.502,
        "x": 0.026,
        "y": 0.056
      },
      "kind": "title",
      "text": "OCS-01 Efficacy and Safety Summary",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "112b2acb-1769-4462-bd52-17bde1957e06",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "39ccec1f-b9f8-4f26-9243-308d832eab28",
      "evidence": "OCS-01 has met the primary endpoints in OPTIMIZE Phase 3 trial, showing superiority over vehicle for treatment of inflammation and pain following cataract surgery",
      "confidence": 0.8
    },
    {
      "name": "Call to action",
      "slug": "call-to-action",
      "agent": null,
      "layer": "slide",
      "matchId": "1bef6873-7a93-4345-9e9c-e69727ae3511",
      "evidence": "Commence a second Phase 3 trial to support NDA submission of OCS-01 for the Treatment of Inflammation and Pain Following Ocular Surgery",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 24,
      "from": 8,
      "beatId": "7992b42b-1916-498c-b92e-c9642604a8e5",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The document presents OCS-01 as a solution, highlighting its efficacy, safety, and potential value to stakeholders (slides 8-24).",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 24,
      "from": 8,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "8c374baa-88d9-4915-a041-aab0dfbd527a",
      "evidence": "The document presents OCS-01 as a solution that addresses the needs of patients and healthcare providers.",
      "position": 1,
      "objective": "How can OCS-01 address the needs of patients and healthcare providers in ocular surgery?",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.7,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}